Biotech Penny Stocks To Watch In April

techmanga June 27, 2021 0 Comments

Top 10 Biotech Penny Stocks to Watch

Following are the top 10 biotech penny stocks to watch today, these are thebiotech penny stocks that made big moves. * Imac Holdings Inc (NASDAQ:IMAC) * Therapeuticsmd Inc (NASDAQ:TXMD) * Nabriva Therape Ads (NASDAQ:NBRV) * Abeona Therapeutics (NASDAQ:ABEO) * Iterum Therapeutics Plc (NASDAQ:ITRM) * Noven Pharmaceuticals, Inc (NASDAQ:NOVN) * Cellectar Biosc (NASDAQ:CLRB) * Teligent Inc (NASDAQ:TLGT) * Agile Therap (NASDAQ:AGRX) * Acelrx Pharmaceutica (NASDAQ:ACRX)

Top 10 Biotech Penny Stocks to Watch

Following are the top 10 biotech penny stocks to watch today, these are thebiotech penny stocks that made big moves. * Imac Holdings Inc (NASDAQ:IMAC) * Therapeuticsmd Inc (NASDAQ:TXMD) * Nabriva Therape Ads (NASDAQ:NBRV) * Abeona Therapeutics (NASDAQ:ABEO) * Iterum Therapeutics Plc (NASDAQ:ITRM) * Noven Pharmaceuticals, Inc (NASDAQ:NOVN) * Cellectar Biosc (NASDAQ:CLRB) * Teligent Inc (NASDAQ:TLGT) * Agile Therap (NASDAQ:AGRX) * Acelrx Pharmaceutica (NASDAQ:ACRX)

Biotech Penny Stocks to Watch This Month

Penny stocks are well-known for their higher level of risk in the stock markettoday. The problem here is that the risk can quickly deter traders andinvestors from even exploring the topic. This is why research is so important.Just taking a dark, blindfolding yourself, and throwing it at the proverbialdartboard isn’t the best way to find top penny stocks to buy. In fact,following the herd or trying to find social media-fueled trades can increasethat risk immensely.There’s no substitute for strong research. Can you get lucky with some of the“Reddit penny stocks,” of course. But luck isn’t a strategy that allows you toprofit consistently. So, where should you begin? You can look for newsheadlines from companies. You can also sift through all of the public filings.Identifying insider buying, material events, quarterly & annual reports areall ways to put together your thesis on why certain companies are worthwatching.Once you’ve got the fundamentals outlined, see what’s happening in the stockmarket. That means looking at the trend “today” as well as the previous trendleading up to it. Is there a strong uptrend, is there tons of volatility, hasthe penny stock been in a strong downtrend? These are basic technical analysisstudies you can do before deciding which names to put on your penny stockslist.Will you always be right about the stocks you’ve done in-depth research on?No, but the more you know about the stocks you want to buy, the easier it isto sift out the noise from things like social media.

Biotech Penny Stocks To Watch Right Now

Despite the lower volume in the overall market, it hasn’t put the brakes onthe latest bull trend. Not only have the S&P and Dow reached fresh, all-timehighs, you’ve also got individual sectors performing their best in history.Healthcare stocks, for instance, have been on a tear. Look at benchmark ETFslike SBI Healthcare ETF (NYSE: XLV), for instance.The ETF hit new, all-time highs this week with a massive move on April 15ththat helped accomplish that. The biotech ETFs like the XBI and IBB also sawstrong rebounds this week. So with all of the positive momentum in the stockmarket today, especially in health-related names, it may not hurt to have somerelated companies on your list of penny stocks to watch right now.

Biotech Penny Stocks To Watch

These biotech penny stocks are on watch, thanks to upcoming events thisquarter. Some of these are more near-term than others. Needless to say, itcould present a risky scenario. Again, the outcome of these events couldtrigger big moves (in either direction) for these penny stocks. With that inmind, will any of these be on your watch list heading into the second half ofQ1?Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch

Biotech Penny Stocks to Watch in the New Year

1. Matinas BioPharma Holdings Inc. (MTNB Stock Report) 2. Palatin Technologies Inc. (PTN Stock Report) 3. Midatech Pharma PLC-ADR (MTP Stock Report) 4. Guardion Health Sciences Inc. (GHSI Stock Report) 5. Immutep Ltd (IMMP Stock Report)

Biotech Penny Stocks to Watch In November 2020

Biotech penny stocks have been making some big headway in the market in thepast six months. Following the advent of Covid, many investors began to hedgebets on biotech stocks for the future. While some stocks that are dealing withCovid are major frontrunners, it seems as though there is a lot of bullishinterest in the biotech space in general. Plenty of these stocks show a lot ofpotential and investors should be aware of a few key factors.For one, biotech penny stocks tend to rise and fall quite quickly in value.This is because they are dependent on regulatory bodies like the FDA to gainapproval for certain pharmaceuticals or substances. This approval can takemonths or even years to see through. But, if they are given approval, it canbe big news for both investors and the company itself. If we look at 2020, wesee that biotechs took a big dive alongside the whole stock market back inMarch. But, since then, many companies have been able to get back on track ina big way.[Read More] Looking For Top Penny Stocks To Buy Now? 5 Marijuana Stocks ToWatchWhile not all biotech companies are working on Covid, the ones that are havereceived massive influxes of capital from the federal government in the U.S.This capital came in the form of Operation Warp Speed, which has the goal ofproducing a vaccine as soon as possible. Because most biotech stocks arecorrelated with one another, investors should always be staying up to date onwhat is going on in the larger biotech space. With all of this in mind, let’stake a look at a few biotech penny stocks to round out the week.

Biotech Penny Stocks to Watch:

1. GT Biopharma Inc. (GTBP Stock Report) 2. Verastem Inc. (VSTM Stock Report) 3. Sesen Bio Inc. (SESN Stock Report) 4. Agenus Inc. (AGEN Stock Report) 5. Dynavax Technologies (DVAX Stock Report)

Biotech Penny Stocks To Watch 1: GT Biopharma Inc.

GT Biopharma Inc. is one of the “non-Covid” biotech penny stocks to watch.There’ve been several key catalysts to note during the past few months. Thereare also updates that I’m sure some traders are anxious to see. The forefrontof these is the upcoming American Society of Hematology Annual Meeting (ASH).The company’s lead treatment for acute myeloid leukemia, GTB-3550, was chosenfor presentation at the ASH meeting.“GTB-3550 TriKE™ for the Treatment of High-Risk Myelodysplastic Syndromes(MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML) Safely DrivesNatural Killer (NK) Cell Proliferation At Initial Dose Cohorts,” is the titleof the abstract set for presentation. If you’re unfamiliar with the magnitudeof the meeting, ASH is the world’s largest professional society serving bothclinicians and scientists around the world who are working to conquer blooddiseases.GTB-3550 recently presented favorable results in an interim Dose Level 3update in September. The treated patient saw a decrease in AML blast levels inbone marrow. There was also an improvement in marrow cellularity. Theimportance here is that this part of the trial is focused on 6 different doselevels. Considering Dose Level 3 was well tolerated, the company seemsconfident in its current approach. In the meantime, there’ve been severalother initiative to expand GT’s novel TriKE treatment platform to addressother cancers too. For more information on GT Biopharma & TriKE, click here.

Biotech Penny Stocks to Watch 2: Verastem Inc.

Verastem Inc. is a development-stage biopharmaceutical company working onseveral new and groundbreaking drugs. These drugs are used to treat thosesuffering from different types of cancers. The company states that its drugpipeline is heavily focused on new “small molecule” drugs that stop tumorgrowth and slow cancer cell survival.Although 2020 has not been a great year for VSTM stock overall, it has shownsome renewed potential in the past month. YTD, VSTM stock is down by around 4%which is not bad considering the plunge that the biotech sector saw in March.On November 5th, shares of VSTM bounced up by a solid 3.2% during intradaytrading.[Read More] 4 Penny Stocks to Buy or Avoid for November 2020; Are They WorthIt?While its performance may not be anything to write home about, the company hasbeen working on several new business developments. At the end of September, itannounced that it completed the sale of its drug, COPIKTRA (duvelisib). Thisis an FDA approved substance used to treat cancer.Verastem stated that it received $70 million in cash from Secura Bio and couldreceive up to $311 million if sales milestones are achieved. Brian Stuglik,CEO of Verastem stated that “this transaction delvers clear benefits for bothVerastem Oncology and Secura Bio.”With a wide breadth of drugs in its pipeline, investors can decide whether ornot VSTM is a biotech stock to watch.

Biotech Penny Stocks to Watch 3: Sesen Bio Inc.

As far as late-stage clinical biotech companies go, Sesen Bio Inc. has a lotgoing for it. The company has been working on several fusion-proteintherapeutics to treat different types of cancer. Similar to Verastem, SesenBio has several drugs in its pipeline that could yield promising results. Thecompany recently announced that its third-quarter results will be available onNovember 9th of this year.With this announcement, the company could show some exciting results for itsflagship drug, Vicineum. Vicineum is a locally administered fusion proteinthat can be used to treat those suffering from late-stage bladder cancers.Sesen Bio has stated that it is currently in the midst of its Phase 3 trialsfor this drug which will evaluate how efficacious it is in treating this typeof cancer.The company has stated that Vicineum is showing potential to boost an anti-tumor response in the body. If it is able to do so, the drug could be combinedwith other cancer treatments to yield more favorable results. Recently, thecompany stated that its drug is being studied by the U.S. National CancerInstitute for its use with AstraZeneca’s drug durvalumab. While this does seemto be a niche area of the biotech industry, cancer treatment has remainedextremely important. If it is able to receive approval for this drug, SesenBio could show some promising momentum. However, investors should continue towatch the company for updates to see if it is right for their portfolio.

Biotech Penny Stocks to Watch 4: Agenus Inc.

Agenus Inc. is another biotech stock that saw some bullish momentum onNovember 5th. During intraday trading, shares of AGEN stock shot up by around3.2%. Thursday proved to be yet another gain of solid bullish momentum for thecompany. On Monday, November 2nd, shares of AGEN stock shot up by around 10%during intraday trading as well. So, why the big bullish interest in thecompany?Well, recently, it stated that it offered the first dose of afenT-797 to aCovid-positive patient. This clinical trial will help to show whether or notthe drug can be used in those with moderate or severe cases of Covid. Inaddition to working on a Covid treatment, the company states that it hasreceived approval from the FDA to see whether or not the same drug could beused to treat cancer patients.[Read More] Small Cap Stocks Continue Rising; 3 Mining Penny Stocks To WatchNowWhile this may seem like another Covid biotech stock, investors should alsonote that the competition is still ongoing. This means that there is plenty ofroom for newcomers to try their hand at solving Covid-related symptoms. Thecompany has stated that the clinical data from its most recent study could beavailable as soon as mid-2021. In addition, it has stated that it could run aphase 2 trial that would allow it to apply for Emergency Use Authorizationwith the FDA. While these types of things do take time, AGEN stock could beworth watching for its progress in this regard.

Biotech Penny Stocks To Watch 5: Dynavax Technologies

Dynavax Technologies has been one of the biotech penny stocks we’ve followedclosely over the last few months. One of the “iffy” parts going into this weekwas Dynavax’s upcoming earnings. Well, those were revealed on Thursday alongwith a slew of other small cap stocks.> “We have entered into numerous collaborations to develop adjuvanted vaccines> across multiple indications, including COVID-19, TdaP, and universal flu.> This portfolio of CpG 1018 opportunities is driving the next leg of growth> beyond HEPLISAV-B, as initially seen with our commercial supply agreement> with Valneva, where we have the potential for 2021 CpG 1018 revenue between> approximately $130 and $230 million.”>> Ryan Spencer , Chief Executive Officer of DynavaxOf note, Dynavax was able to beat on both earnings per share and sales. Thecompany reported an EPS loss of 15 cents while expectations pegged it at a$0.20 loss. Furthermore, sales figures beat estimates by 42%, coming in at$13.41 million for the quarter.Click here for full disclaimer* * ** * *Midam Ventures, LLC | (305) 306-3854 | 1501 Venera Ave, Coral Gables, FL 33146| news@pennystocks.comPenny Stocks on Robinhood to Watch in 2021Gated Content

Biotech Penny Stocks To Watch In April

As the saying goes, “A rising tide lifts all ships.” In this case, investorswill seek out which broad sector or industry trends positively impact relatedstocks. This month, Healthcare and health-related names have benefitedgreatly. Take a look at the Select SPDR Trust Healthcare ETF (NYSE: XLV).April 20th was the 8th day in a row that the ETF posted a green close. Sincethe start of the month, the XLV jumped over 5% so far.A mix of pandemic headlines and speculative trading trends have helped givestocks related to healthcare a boost. Furthermore, certain biotech ETF’s likethe NASDAQ IBB have also begun climbing. With this in mind, it may not be badto put together a list of penny stocks to watch with exposure to these bullishtrends. 1. GT Biopharma Inc. (NASDAQ: GTBP) 2. Senseonics Holdings Inc. (NYSE: SENS) 3. Avinger, Inc (NASDAQ: AVGR)

3 Biotech Penny Stocks to Watch This Month

As we head toward the middle of January, there are plenty of penny stocks thatare showing potential. This week got off to an interesting start, with mostblue-chip stocks trading lower. However, as the day progressed we watched manystocks move higher. In the stock market today, there are quite a fewuncertainties. First, the pandemic continues to be a major theme that has alarge impact on trading. Second, Joe Biden’s presidency will begin on January20th, which in itself has several implications.Despite these factors, we are seeing biotech stocks hover near all-time highs.Take a look at one of the benchmark ETFs for the sector. The Nasdaq BiotechETF (NASDAQ: IBB) came within less than 50 cents of retesting all-time highsthis week. On Friday, the ETF hit a high of $159.61 to make a new milestonehigh. It appears as though investors are confident about the economy asvaccines continue to be distributed.While the latter half of 2020 was a great period for most stocks, 2021 couldhold even more potential. If vaccines continue to be distributed in a fastmanner, the economy could recover and hopefully, that will be back to pre-pandemic levels. At the center of it all, healthcare and biopharma remain aclear focus for traders. In light of this, here are five biotech penny stocksto watch as January rolls on.

Biotech Penny Stocks To Watch:

1. GT Biopharma Inc. (GTBP Stock Report) 2. Corbus Pharmaceuticals Holdings Inc. (CRBP Stock Report) 3. BioDelivery Sciences (BDSI Stock Report) 4. GlycoMimetics Inc. (GLYC Stock Report) 5. PDS Biotechnology Corporation (PDSB Stock Report)

Biotech Penny Stocks To Watch 1: GT Biopharma Inc.

GT Biopharma Inc. is one of the immunotherapy stocks that’ve gained interestover the last few weeks. Mainly for its TriKE treatment platform, GT hascontinued making progress on several fronts. TriKE™ is a combination proteinthat bridges an immune cell and a tumor cell to drive tumor cell killing powerexponentially. It has led to new first-in-human phase studies to treat acutemyeloid leukemia via GTB-3550.The company recently completed treatment of the first patient enrolled at DoseLevel 3 in its GTB-3550 TriKE™ Phase I/II clinical trial. In short, thefindings showed promise including a noticeable decrease in AML blast levels.There was also an improvement in platelet and red blood cells numbers. Interimresults were also chosen for inclusion for presentation at the AmericanSociety of Hematology Annual Meeting. What’s more, is that GTB-3550 isn’t theonly thing that TriKE is being utilized in. The company has continuedexpanding upon several new initiatives.A recent publication in the journal Cancers also expanded upon TriKE’spotential. The company said that this specific a B7H3-targeted TriKE™ “has thepotential to enhance natural killer cell immunotherapy in solid tumorsettings”. Furthermore it supported its further clinical development.

Biotech Penny Stocks To Watch 2: Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc.has been trying to recover afterplummeting back in September. Corbus reported no significant differences inprimary and secondary endpoints for its Phase 3 lenabasum study. This is thecompany’s utaneous systemic sclerosis treatment candidate.> “We are surprised and deeply disappointed that the RESOLVE-1 trial did not> meet its primary endpoint. I would like to extend my gratitude to the> participants in the study and the clinical staff at the study sites, as well> as to the Corbus employees, for their hard work and dedication. We now look> forward to upcoming topline results from our study of lenabasum in patients> with cystic fibrosis.”>> Yuval Cohen , Ph.D., Chief Executive Officer of CorbusAside from these data, what could have CRBP in the spotlight is itsrelationship to cannabis. We all know marijuana penny stocks are on the riseafter recent legislative moves in the U.S. Furthermore, big news from Aphria(APHA Stock Report) entering the U.S. market via the acquisition of SweetwaterBrewing Company has traders looking for sympathy trades. Corbus’ lenabasum, isan oral, selective cannabinoid receptor type 2 agonist that resolves chronicinflammation. We’ll have to see if Wednesday’s sympathy momentum carriesthrough the rest of the week.

Biotech Penny Stocks To Watch 3: BioDelivery Sciences

BioDelivery Sciences joins the list after catching some late afternoonmomentum on Wednesday. The specialty pharmaceutical company focuses onaddressing chronic pain diseases. Around 5:10 PM EST, the company came outwith several key updates. First, BioDelivery reported that Jeff Bailey wouldbecome the permanent CEO of the company. Bailey was acting as interim CEOsince May 2020 while continuing to serve on the Board of Directors. Hisexperience involves over 20 years at Jonhson & Johnson/JanssenPharmaceuticals. He also served roles at Novartis as well as Neurovance.Read MoreWhat’s more, the company also announced a $25 million share repurchaseprogram. CEO Bailey explained, “We remain focused on balancing our disciplinedapproach to capital allocation against growth opportunities available to BDSI,including continuing to invest in the organic growth of our portfolio alongwith pursuing strategic acquisitions that will continue to drive long-termshareholder value.”With that, shares popped during after-hours trading. Will BDSI be on the listof penny stocks to watch on Thursday?

Biotech Penny Stocks To Watch 4: GlycoMimetics Inc.

GlycoMimetics Inc. was a late-breaking mover on Wednesday. The company focuseson rare cancers and addressing metastatic spread. On Wednesday, GlycoMimeticsshares popped late in the afternoon following its latest update on upcomingpresentations. The company announced that 3 abstracts have been accepted fororal presentations and two abstracts have been accepted for posterpresentations at the 62nd American Society of Hematology Annual Meeting andExposition. These include data from the company’s clinical and researchportfolio.The data convey new insights into the critical role of E-selectin in bothmalignant and inflammatory, adhesion-mediated conditions, suggesting noveltreatment options for unmet need in sickle cell disease and AML,” said HelenThackray, MD, FAAP, GlycoMimetics’ Chief Medical Officer.Much like traders could track GTBP ahead of this conference, GLYC might alsobecome one to watch in anticipation for what’s to be presented at this majorindustry conference.

Leave a Reply

Your email address will not be published. Required fields are marked *